Persomics, a growing company with innovative solutions that miniaturize, accelerate and increase the scale of phenotypic screening, announced its first custom services agreement with NovellusDx, the leading Precision Cancer Analysis company.(PRWeb October 22, 2015)Read the full story at http://www.prweb.com/releases/2015/10/prweb13034790.htm